Fluorouracil (5‑FU) – Patient Guide (UK)

Fluorouracil (often shortened to 5‑FU) is a chemotherapy medicine used to treat several cancers. It works by interfering with how rapidly dividing cancer cells build and repair their DNA. Fluorouracil is available in different formulations, commonly as an injection given by healthcare professionals, and sometimes as other administration forms depending on the product.

This guide explains how Fluorouracil works, how it is used, what to expect, and key safety information for people in the United Kingdom. It is written in a patient-friendly way and is not a substitute for advice from your oncology team.

Basic product information

Important: Fluorouracil can cause significant side effects. Your treatment plan is individual and depends on cancer type, stage, previous treatments, organ function, and blood test results.

How Fluorouracil works (mechanism of action)

Fluorouracil is an antimetabolite. After it enters the body, it is converted into active compounds that disrupt cell division:

• Interferes with DNA synthesis: Fluorouracil can inhibit key enzymes needed to make DNA building blocks, slowing down or stopping growth of rapidly dividing cells.
• Disrupts RNA processing: It can also affect the processing of RNA (instructions cells use to make proteins), further hindering cancer cell survival.
• Targets fast-growing cells: Cancer cells typically divide faster than normal cells, making them more vulnerable to these effects.

While it primarily targets cancer cells, some normal tissues that also divide quickly (such as those lining the mouth and gut, and bone marrow where blood cells are made) can be affected, which is why side effects such as mouth sores and low blood counts may occur.

Pharmacokinetics (how the body processes it)

Pharmacokinetics describes how a medicine is absorbed, distributed, metabolised, and eliminated.

• Absorption: Depending on the formulation, Fluorouracil is administered directly into the body (commonly by infusion), so absorption through the gut is not the main route.
• Distribution: It circulates in the bloodstream and can reach tissues, including those where cancer is present.
• Metabolism: Fluorouracil is broken down mainly in the liver and other tissues. An important factor in metabolism involves pathways such as dihydropyrimidine dehydrogenase (DPD).
• Elimination: It and its metabolites are removed mainly through the kidneys.
• Half-life and timing: The timing of infusion schedules is designed to expose cancer cells to effective drug concentrations while allowing the body time to recover between cycles.

Clinical relevance: People with reduced DPD activity may be at increased risk of severe toxicity. In many settings, clinicians may check DPD-related risk factors or follow protocols to adjust treatment safely.

Typical use in the UK (indications)

Fluorouracil is used for a range of cancers, often as part of combination chemotherapy regimens. The exact use depends on cancer type and treatment goals (curative, adjuvant, or palliative).

Common cancer indications include:

• Colorectal cancer (colon and rectum), including advanced disease and treatment around surgery in selected cases
• Gastric (stomach) cancer and some oesophagogastric cancers (often in combination regimens)
• Breast cancer in certain protocols
• Head and neck cancers (selected regimens)
• Other solid tumours where Fluorouracil is part of established treatment protocols

Combination therapy is common: Fluorouracil is frequently combined with other agents such as leucovorin and/or other chemotherapy medicines to improve effectiveness.

Timing and treatment schedules

Fluorouracil treatment is usually planned in cycles. Your oncology team determines:

• Day-by-day schedule (for injections/infusions)
• Length of infusion (short infusion vs longer continuous infusion, depending on regimen)
• Cycle interval (for example, every 2 or 3 weeks, depending on the protocol)
• Blood test monitoring before each cycle
• Dose adjustments if side effects occur

What to expect: Many side effects tend to appear within days after treatment and may peak at specific times depending on the regimen. Your team will tell you what timing to watch for (for example, mouth sores, diarrhoea, fatigue, or infections).

Food interactions (can you eat normally?)

Food interactions: Fluorouracil is typically administered by injection/infusion. In most circumstances, food does not directly interact with how the medicine works.

However, nutrition matters during chemotherapy:

• Diarrhoea or nausea: Some people find that bland, small meals are easier. Your team may recommend anti-diarrhoeal or anti-sickness medicines.
• Mouth sores: Avoid spicy, acidic, or very hot foods if they worsen discomfort.
• Hydration: If you get diarrhoea, staying hydrated is important.

If you experience significant swallowing problems, persistent vomiting, or dehydration, seek medical advice promptly.

Alcohol and medicine interactions

Alcohol: There is no single universal “safe amount” of alcohol during Fluorouracil treatment, because alcohol can worsen common chemotherapy effects such as nausea, fatigue, dehydration, and irritation of the digestive system. Alcohol may also affect liver function and overall nutrition.

• General advice: It is often best to avoid alcohol during treatment or keep it to a minimum, especially if you have diarrhoea, vomiting, mouth sores, liver concerns, or low appetite.
• Talk to your team: Your oncology pharmacist or doctor can advise based on your overall health and regimen.

Drug interactions: Fluorouracil may interact with other medicines indirectly through effects on metabolism and bleeding risk, depending on the broader regimen. Tell your healthcare team about:

• All medicines you take (including over-the-counter remedies)
• Herbal supplements (for example, St John’s wort)
• Vitamin supplements (especially if you take high doses)
• Any blood-thinning medicines

Your oncology team can check interactions more precisely because Fluorouracil is often used with other medicines that have their own interaction profiles.

Dosing (general information)

Dose is individual. Fluorouracil dosing is commonly based on body surface area (BSA) and adjusted based on tolerability and blood test results. Regimens vary widely, so the dose and schedule depend on what protocol you are receiving.

How dosing decisions are made

• Cancer type and stage
• Whether it is used alone or with other medicines
• Blood counts (neutrophils, platelets, haemoglobin)
• Organ function (especially liver and kidney function)
• Previous chemotherapy and current side effects
• DPD-related risk if identified or suspected

Do not self-adjust: If you miss an appointment or your treatment is delayed, contact your treatment unit. Dose changes are made based on clinical assessment.

Safety profile: who needs extra caution?

Fluorouracil has a well-known safety profile. Most side effects are manageable, but some can be serious and require prompt attention.

Common side effects

• Low blood counts (leading to infection risk, fatigue, or easy bruising/bleeding)
• Mouth sores (stomatitis)
• Diarrhoea
• Nausea and/or vomiting
• Hair thinning or hair changes (varies by regimen)
• Fatigue
• Loss of appetite
• Skin changes (dryness or rash in some patients)

Serious side effects – seek urgent help

Contact your emergency services or your oncology team urgently if you develop any of the following:

• Signs of infection, such as fever (often defined by your clinic), chills, or feeling very unwell
• Severe diarrhoea or dehydration
• Severe mouth sores preventing eating/drinking
• Shortness of breath, chest pain, or severe allergic-type reactions
• Uncontrolled bleeding or black/tarry stools

Because severity can vary, your care team will give you clear “what to do” instructions, including specific fever thresholds if applicable.

Extra caution may be needed if you have:

• Known DPD deficiency or previous severe reactions to fluoropyrimidines
• Significant liver or kidney impairment
• A history of severe heart disease (some patients experience cardiovascular symptoms during treatment)
• Prior extensive radiation or chemotherapy that may affect bone marrow reserve

Practical use tips (making treatment days easier)

Although Fluorouracil is administered by professionals, there are practical steps you can take to prepare and manage side effects.

Before your appointment

• Keep track of symptoms from previous cycles (diarrhoea, mouth sores, nausea, fatigue).
• Prepare a list of medicines you take, including vitamins, herbal products, and pain relief.
• Plan transport and support for days when you may feel tired or unwell.

During treatment

• Hydration: Sip fluids if you are able, especially if you tend to develop diarrhoea.
• Mouth care: Gentle oral care (as recommended by your team) can help reduce mouth soreness.
• Preventing infection: Practise good hygiene and avoid close contact with people who are obviously unwell.
• Report changes early: Early reporting of diarrhoea or fever can improve outcomes.

After treatment (the recovery period)

• Watch the pattern: Side effects often follow a predictable timeline for each person.
• Nutrition: If appetite is poor, consider high-calorie, high-protein options (and ask about dietary support).
• Rest safely: Fatigue is common. Balance light activity with rest.

Emergency plan: Know who to call (hospital number vs urgent care route) if symptoms become severe.

Alternative options (other treatments that may be used)

Whether you can use alternatives depends on your cancer type, previous treatments, and overall health. In many cases, doctors choose between different chemotherapy agents or combination regimens.

Possible alternative chemotherapies (examples)

• Different fluoropyrimidines (depending on regimen and local practice), such as capecitabine in some colorectal cancer protocols
• Other cytotoxic agents used in combination regimens (for example, oxaliplatin, irinotecan, taxanes, platinum-based treatments depending on cancer type)
• Biological therapies and/or immunotherapies in selected cancers, depending on biomarkers and stage

Your oncology team can explain why Fluorouracil is chosen and what other options exist if you cannot tolerate it or if the disease is not responding.

Market and legal context for the UK

In the United Kingdom, Fluorouracil is regulated as a medicinal product and is supplied under healthcare pathways that support safe prescribing, handling, and administration. Chemotherapy medicines are typically delivered and used through specialist services to ensure correct dosing, monitoring, and management of adverse effects.

Pharmacovigilance: Like all medicines, reports of suspected side effects contribute to ongoing safety monitoring. Healthcare professionals and patients are encouraged to report concerns through the appropriate UK channels.

NHS and private care: Many patients receive chemotherapy via NHS oncology services, though some care may be provided through private hospitals. In both settings, treatment quality and safety processes are expected to meet regulatory standards.

Recent guidance and monitoring (what is commonly followed)

Clinical practice in the UK continues to emphasise safety monitoring for fluoropyrimidines:

• Blood tests before each cycle to confirm safe levels of white blood cells and platelets.
• Assessment of symptoms such as diarrhoea, mouth ulcers, and infection signs.
• DPD-related safety awareness: Reduced DPD activity can increase the risk of severe toxicity. Many protocols include risk assessment and close monitoring; some services incorporate testing where appropriate.
• Early intervention for complications to prevent dehydration and serious infections.

Your clinic may also use treatment-specific supportive medicines (for example, anti-sickness medicines or mouth care strategies) based on the regimen.

Delivery and availability (UK online pharmacy information)

Because Fluorouracil is a chemotherapy medicine typically administered in specialist settings, availability can vary by formulation and clinic pathway. If your treatment requires hospital administration, medicines are usually arranged through your healthcare provider rather than directly “over-the-counter” purchase.

Where a supplier can arrange delivery, common expectations include:

• Cold-chain or specific storage requirements (depending on the product).
• Special handling and controlled distribution to the intended clinical setting.
• Packaging and labelling consistent with healthcare standards.

Availability: Stock levels can fluctuate. If you are purchasing supportive medicines (such as anti-sickness tablets or mouth treatments), these are more likely to be available for home delivery. For Fluorouracil itself, arrangements are usually handled through your oncology service.

If you have questions about delivery timelines, storage, or suitability, contact the pharmacy team directly.

FAQ – Fluorouracil (5‑FU)

1) What is Fluorouracil used for?

Fluorouracil is used to treat certain cancers, most commonly colorectal cancer and other solid tumours, often as part of combination chemotherapy regimens. Your oncology team will explain the specific intent of your treatment (for example, to shrink the tumour, after surgery, or to control symptoms).

2) How is Fluorouracil given?

Fluorouracil is typically administered by injection or infusion by trained professionals in a hospital or specialist setting. The exact timing (short vs continuous infusion) depends on the regimen you receive.

3) When will side effects start?

Many side effects begin within days of treatment. For example, mouth soreness and diarrhoea may appear relatively soon after infusion, while fatigue can build over the days following treatment. Your clinic will provide guidance on when to expect certain effects and when to call them.

4) Can I eat normally during treatment?

Often, yes—unless you have nausea, mouth sores, or diarrhoea. Eating smaller meals, choosing bland foods, staying hydrated, and avoiding foods that make symptoms worse can help. A dietitian may be able to support you.

5) Is it safe to drink alcohol?

Alcohol may worsen dehydration, nausea, and digestive irritation, and it can negatively affect nutrition and liver function. Many people are advised to avoid alcohol or keep it to a minimum during chemotherapy. Ask your care team for advice tailored to you.

6) What should I do if I get diarrhoea?

Report diarrhoea promptly to your oncology team. They may prescribe anti-diarrhoeal medicines and advise fluid intake. Severe diarrhoea can become an emergency due to dehydration and infection risk.

7) What if I get a fever?

Fever during chemotherapy can be serious. Follow your clinic’s instructions about when to call and what temperature threshold to treat as urgent. If you cannot reach your team, seek urgent medical help.

8) Are there interactions with other medicines?

Yes, interactions can occur—especially depending on the combination regimen. Tell your healthcare team about all medicines and supplements you take, including over-the-counter products and herbal remedies.

9) What monitoring is done during treatment?

Monitoring often includes regular blood tests (to check white blood cells and platelets), symptom checks at appointments, and assessment of organ function based on your treatment plan.

10) What alternatives exist if Fluorouracil isn’t suitable?

Your oncologist may consider other chemotherapy agents or different regimens. In some cancers, targeted therapies or immunotherapies may also be options depending on biomarkers and disease characteristics.

Need further help? If you have questions about your specific regimen, side effects, or how to manage symptoms, speak to your oncology team. If you think you may be experiencing a serious reaction (such as fever or severe diarrhoea), seek urgent medical assistance.